Literature DB >> 3509671

Characterization of variable-region genes and shared crossreactive idiotypes of antibodies specific for antigens of various influenza viruses.

T M Moran1, M Monestier, A C Lai, G Norton, M A Reale, M A Thompson, J L Schulman, R Riblet, C A Bona.   

Abstract

Several syngeneic monoclonal anti-idiotypic antibodies were obtained against PY206, a monoclonal antibody specific for X-31 (H3N2) influenza virus hemagglutinin. This idiotype was found in the sera of BALB/c mice immunized with various influenza viruses. Adsorption experiments indicated that the PY206 Id was borne by antibodies specific for viral hemagglutinin (HA) and/or neuraminidase (NA). This idiotype was identified on other monoclonal antibodies specific for various influenza HAs (H3 and H1). Study of the variable-region (V) genes of these monoclonal antibodies showed that its expression is independent of variable kappa (VK)21 light-chains and that the heavy-chains of the strongly idiotype-positive hybridomas derive from either the variable heavy (VH) J558 or VH 7183 family. Finally, Western blot analysis demonstrated that PY206 idiotypic determinants are located exclusively on the heavy chain.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3509671     DOI: 10.1089/vim.1987.1.1

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  8 in total

1.  Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus.

Authors:  Wenqian He; Gene S Tan; Caitlin E Mullarkey; Amanda J Lee; Mannie Man Wai Lam; Florian Krammer; Carole Henry; Patrick C Wilson; Ali A Ashkar; Peter Palese; Matthew S Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-03       Impact factor: 11.205

2.  Molecular basis for expression of the A48 regulatory idiotope on antibodies encoded by immunoglobulin variable-region genes from various families.

Authors:  H Zaghouani; F A Bonilla; K Meek; C Bona
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

3.  Human monoclonal anti-idiotypic antibody to the tumour-associated antibody 791T/36.

Authors:  E B Austin; R A Robins; L G Durrant; M R Price; R W Baldwin
Journal:  Immunology       Date:  1989-08       Impact factor: 7.397

4.  Activation of clones producing self-reactive antibodies by foreign antigen and antiidiotype antibody carrying the internal image of the antigen.

Authors:  N C Bailey; V Fidanza; R Mayer; G Mazza; M Fougereau; C Bona
Journal:  J Clin Invest       Date:  1989-09       Impact factor: 14.808

5.  Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact.

Authors:  Paul E Leon; Wenqian He; Caitlin E Mullarkey; Mark J Bailey; Matthew S Miller; Florian Krammer; Peter Palese; Gene S Tan
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-19       Impact factor: 11.205

6.  Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins.

Authors:  Taia T Wang; Gene S Tan; Rong Hai; Natalie Pica; Erin Petersen; Thomas M Moran; Peter Palese
Journal:  PLoS Pathog       Date:  2010-02-26       Impact factor: 6.823

7.  Autoantibodies of various specificities encoded by genes from the VH J558 family bind to foreign antigens and share idiotopes of antibodies specific for self and foreign antigens.

Authors:  M Monestier; B Bonin; P Migliorini; H Dang; S Datta; R Kuppers; N Rose; P Maurer; N Talal; C Bona
Journal:  J Exp Med       Date:  1987-10-01       Impact factor: 14.307

8.  Broadly Neutralizing Hemagglutinin Stalk-Specific Antibodies Induce Potent Phagocytosis of Immune Complexes by Neutrophils in an Fc-Dependent Manner.

Authors:  Caitlin E Mullarkey; Mark J Bailey; Diana A Golubeva; Gene S Tan; Raffael Nachbagauer; Wenqian He; Kyle E Novakowski; Dawn M Bowdish; Matthew S Miller; Peter Palese
Journal:  mBio       Date:  2016-10-04       Impact factor: 7.867

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.